Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval).
Shah RR; Morganroth J; Shah DR; Drug Safety: An International Journal Of Medical Toxicology And Drug Experience, 2013, vol. 36, issue 5, p 295, ISSN 01145916. ISBN 01145916.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef